Watchlist Price Alert

Xeris Biopharma Inc. (XERS)

NASDAQ: XERS · Real-Time Price · USD

4.73

0.33 (7.50%)

At close: Jun 17, 2025, 10:53 AM

Xeris Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	71.62M	67.45M	121.97M	121.97M	67.27M	37.6M	45.72M	42.05M	32.27M
Short-Term Investments	n/a	5M	n/a	35.16M	35.16M	96.19M	66.92M	n/a	n/a
Long-Term Investments	4.12M	n/a	4.35M	-364K	n/a	13.23M	n/a	n/a	n/a
Other Long-Term Assets	1.28M	4.54M	267K	4.73M	829K	-13M	95K	157K	47K
Receivables	40.41M	39.2M	30.83M	17.46M	6.88M	4.69M	2.87M	1.2M	101K
Inventory	48.17M	38.84M	24.73M	24.73M	18.12M	8.35M	n/a	n/a	n/a
Other Current Assets	7.45M	5.78M	9.29M	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	167.66M	156.26M	186.82M	186.82M	142.6M	152.21M	117.9M	44.05M	33.17M
Property-Plant & Equipment	28.21M	29.18M	28.38M	28.38M	6.63M	6.71M	2.03M	788K	312K
Goodwill & Intangibles	121.78M	132.62M	124.6M	124.6M	154.31M	n/a	n/a	n/a	n/a
Total Long-Term Assets	161.49M	166.34M	157.7M	157.7M	161.76M	6.94M	2.13M	945K	359K
Total Assets	323.06M	322.6M	344.52M	344.52M	304.36M	159.15M	120.03M	45M	33.53M
Account Payables	2.29M	11.56M	4.61M	8.92M	3.12M	5.6M	866K	1.98M	1.31M
Deferred Revenue	n/a	n/a	64.78M	n/a	n/a	n/a	232K	234K	263K
Short-Term Debt	15.1M	n/a	1.58M	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	39.75M	51.43M	25.65M	18.95M	4.02M	2.24M	4.98M	1.3M	468K
Total Current Liabilities	100.44M	95.19M	73.62M	73.62M	79.04M	28.21M	10.17M	4.86M	2.53M
Long-Term Debt	217.01M	190.93M	187.07M	88.07M	87.02M	58.3M	31.89M	n/a	n/a
Other Long-Term Liabilities	1.97M	6.23M	25.72M	37.08M	10.16M	8.91M	2.56M	97.97M	62.94M
Total Long-Term Liabilities	252.23M	234.19M	225.71M	225.71M	130.09M	97.18M	34.45M	97.97M	62.94M
Total Liabilities	352.68M	329.38M	299.33M	299.33M	209.13M	125.39M	44.62M	102.83M	65.47M
Total Debt	271.45M	229.19M	198.06M	198.06M	88.07M	87.02M	31.89M	n/a	n/a
Common Stock	15K	14K	14K	14K	13K	6K	2K	1K	1K
Retained Earnings	-671.86M	-617.02M	-554.77M	-554.77M	-460.11M	-337.38M	-120.67M	-60.59M	-34.03M
Comprehensive Income	-25K	-25K	-23K	-23K	-31K	6K	-52K	-440K	-268K
Shareholders Equity	-29.61M	-6.78M	45.19M	45.19M	95.23M	33.76M	75.41M	-57.83M	-31.93M
Total Investments	n/a	5M	4.35M	35.16M	35.16M	96.19M	66.92M	n/a	n/a